Homepage
Author:
GRAIL, Inc.
Posted Date:
June 1, 2026
GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Diagnoses at 2026 ASCO Annual Meeting
GRAIL, Inc.
June 1, 2026
GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annual Meeting
GRAIL, Inc.
May 31, 2026
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GRAIL, Inc.
May 27, 2026
GRAIL to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
GRAIL, Inc.
May 26, 2026
GRAIL to Present at the 2026 Jefferies Global Healthcare Conference
GRAIL, Inc.
May 21, 2026
GRAIL Reports First Quarter 2026 Financial Results
GRAIL, Inc.
May 5, 2026
GRAIL to Present at the BofA Securities 2026 Health Care Conference
GRAIL, Inc.
April 30, 2026
GRAIL to Announce First Quarter 2026 Financial Results
GRAIL, Inc.
April 22, 2026
GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at 2026 ASCO Annual Meeting
GRAIL, Inc.
April 21, 2026
GRAIL Announces Integration of the Galleri® Test into Epic Electronic Health Record Platform to Expand Access Nationwide
GRAIL, Inc.
April 7, 2026
1
2
Next
